
Viemed Healthcare, Inc.
VMDNASDAQHealthcareMedical - Care Facilities
Previous close
$8.85
+$0.28 · +3.27%
VMD company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
68
Undervalued
Momentum
69
Gaining
Sentiment
56
Mixed
Risk resilience
73
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteViemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Casey Hoyt
- Listed since
- Aug 9, 2019
- Employees
- 1,438
Market position
Day range
Current $8.85
52-week range
Current $8.85
- Open
- $8.59
- Previous close
- $8.57
- Volume
- 1.07M
- 3.25× average
- Average volume
- 330.37K
- Average daily volume
- Market cap
- 337.08M USD
- Beta
- 1.12
- Market reference 1
- 50-day average
- $10.9395
- -19.10% below average
- 200-day average
- $9.0083
- -1.76% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 291.44M USD
- P/E (TTM)
- 23.46×
- P/B (TTM)
- 2.35×
- P/S (TTM)
- 1.12×
- EV / EBITDA
- 5.65×
- Earnings yield
- 5.17%
- Free cash flow yield
- 4.13%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 57.21%
- Operating margin
- 8.14%
- Net margin
- 4.81%
- Return on equity
- 10.55%
- Return on assets
- 6.95%
- Return on invested capital
- 8.30%
Financial health
- Debt / equity
- 0.08×
- Current ratio
- 1.18×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 270.28M USD | 224.26M USD | 183.01M USD | 138.83M USD | 117.06M USD |
| Cost of goods sold | 114.82M USD | 91.05M USD | 70.23M USD | 54.15M USD | 43.65M USD |
| Gross profit | 155.46M USD | 133.2M USD | 112.78M USD | 84.68M USD | 73.41M USD |
| Research and development | 3.02M USD | 3.07M USD | 2.78M USD | 2.7M USD | 2.11M USD |
| Selling, general, and administrative | 130.5M USD | 112.48M USD | 93.73M USD | 73.36M USD | 60.04M USD |
| Operating expenses | 134.75M USD | 115.3M USD | 98.45M USD | 76.43M USD | 61.83M USD |
| Interest expense | 1.18M USD | 776K USD | 424K USD | 197K USD | 318K USD |
| Depreciation and amortization | 28.61M USD | 25.37M USD | 21.86M USD | 15.63M USD | 11.31M USD |
| Operating income | 20.71M USD | 17.9M USD | 14.33M USD | 8.25M USD | 11.58M USD |
| Net income | 14.93M USD | 11.27M USD | 10.24M USD | 6.22M USD | 9.13M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 18%
- 2 beats, 7 misses, 2 met estimates
- Average EPS surprise
- -13.09%
- 11 comparable reports
- Latest EPS result
- 0.07
- Estimate 0.12 · Miss by 41.67%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
VMD news
VMD peers
ETFs holding VMD
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI10.65M0.00%2.3T USD0.03%$378.24—
Vanguard Extended Market ETFVXF4.44M0.00%93.7B USD0.05%$245.53—
Vanguard Russell 2000 ETFVTWO2.24M0.01%17.4B USD0.06%$121.25—
First Trust Dow Jones Select MicroCap Index FundFDM1.54M0.37%423.22M USD0.65%$92.96—
Vanguard Russell 2000 Growth ETFVTWG427.72K0.02%1.7B USD0.06%$282.73—
State Street SPDR US Small Cap Low Volatility Index ETFSMLV209K0.08%——$159.7—
Global X - Russell 2000 ETFRSSL142.34K0.01%1.53B USD0.08%$117.49—
Invesco RAFI US 1500 Small-Mid ETFPRFZ109.9K0.00%——$55.89—
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 10.65M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24—
Vanguard Extended Market ETFVXF- Market value
- 4.44M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53—
Vanguard Russell 2000 ETFVTWO- Market value
- 2.24M
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25—
First Trust Dow Jones Select MicroCap Index FundFDM- Market value
- 1.54M
- Weight
- 0.37%
- AUM
- 423.22M USD
- Expense ratio
- 0.65%
- Price / 1D
- $92.96—
Vanguard Russell 2000 Growth ETFVTWG- Market value
- 427.72K
- Weight
- 0.02%
- AUM
- 1.7B USD
- Expense ratio
- 0.06%
- Price / 1D
- $282.73—
State Street SPDR US Small Cap Low Volatility Index ETFSMLV- Market value
- 209K
- Weight
- 0.08%
- AUM
- —
- Expense ratio
- —
- Price / 1D
- $159.7—
Global X - Russell 2000 ETFRSSL- Market value
- 142.34K
- Weight
- 0.01%
- AUM
- 1.53B USD
- Expense ratio
- 0.08%
- Price / 1D
- $117.49—
Invesco RAFI US 1500 Small-Mid ETFPRFZ- Market value
- 109.9K
- Weight
- 0.00%
- AUM
- —
- Expense ratio
- —
- Price / 1D
- $55.89—
Continue in GoAI
Research VMDresearch.disclaimer











